C
Chemistree Technology Inc
CNSX:CHM
Chemistree Technology Inc
CNSX:CHM
Price:
0.005
CAD
Market Cap:
CA$3.7m
Chemistree Technology Inc
Research & Development
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Chemistree Technology Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Chemistree Technology Inc
CNSX:CHM
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Research & Development
-$629m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Research & Development
-CA$478k
|
CAGR 3-Years
44%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Research & Development
-$4.4m
|
CAGR 3-Years
30%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Research & Development
-$105.2m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
-152%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Research & Development
-CA$27.1m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-26%
|
|
No Stocks Found
Chemistree Technology Inc
Glance View
Chemistree Technology Inc. is an investment company, which focuses on making investments or acquisitions in areas relating to the U.S. cannabis sector, and provides turn-key solutions for the U.S. regulated cannabis industry, and branding, licensing and marketing strategies to existing participants. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-09-29. The firm operates through its wholly owned subsidiaries, American CHM Investments Inc., CHM Desert LLC and Chemistree Washington Ltd. The firm is focused on investments across a range of industries and is seeking to invest in early stage.
CHM
Intrinsic Value
Not Available
C
